Effect of pirfenidone on chronic interstitial pneumonia

H. Takoi, Y. Miura, Y. Tsunoda, Y. Sumazaki, T. Tanaka, S. Y. Lin, Y. Yatagai, A. Sekine, K. Hayashihara, T. Saito (Ibaraki, Tokyo, Japan)

Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Session: Diffuse parenchymal lung disease III
Session type: Thematic Poster Session
Number: 3653
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Takoi, Y. Miura, Y. Tsunoda, Y. Sumazaki, T. Tanaka, S. Y. Lin, Y. Yatagai, A. Sekine, K. Hayashihara, T. Saito (Ibaraki, Tokyo, Japan). Effect of pirfenidone on chronic interstitial pneumonia. Eur Respir J 2012; 40: Suppl. 56, 3653

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 50 (4) 1701157; 10.1183/13993003.01157-2017
Year: 2017



Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Source: Eur Respir J 2005; 25: 528-533
Year: 2005



Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002

Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013


Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002



Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Intravenous pulse doses of high-dose corticosteroid and cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Causes of chronic cough in patients with interstitial pneumonia
Source: Annual Congress 2008 - Lung function, airways and cough
Year: 2008

Ciprofloxacin-induced acute interstitial pneumonitis
Source: Eur Respir J 2004; 23: 172-174
Year: 2004



Acute exacerbations of idiopathic pulmonary fibrosis and the role of corticosteroids
Source: Breathe, 16 (3) 200086; 10.1183/20734735.0086-2020
Year: 2020



Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009



Chronic hypersensitivity pneumonitis and its differential diagnosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189
Year: 2007

Effect of baseline statin use on benefit of nintedanib
Source: International Congress 2016 – IPF treatment II
Year: 2016


The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008



Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002



Acute exacerbations of progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180071; 10.1183/16000617.0071-2018
Year: 2018



Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia
Source: Eur Respir J 2015; 45: 1624-1631
Year: 2015



Clinical efficacy of pirfenidone in patients with severe fibrosing interstitial pneumonia
Source: International Congress 2015 – Treatment of IPF
Year: 2015


Acute exacerbations of interstitial lung disease
Source: Eur Respir Monogr 2016; 74: 117-131
Year: 2016


Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013